Browsing Сотрудничество – катализатор инновационного роста by Author "Руденко, Э. В."
Now showing items 1-1 of 1
-
Фармакогенетические аспекты антирезорбтивной терапии остеопороза
Морозик, П. М.; Алекна, В.; Руденко, Э. В.; Тамулайтене, М.; Кобец, Е. В. (БНТУ, 2020)Treatment strategy of osteoporosis (OP) is mainly based on increase in bone mineral density (BMD) and reduction of fracture risk. Bisphosphonates (BPs) are the most commonly used first-line antiresorptive agents. However, up to 30–50% of OP patients exhibit inadequate treatment response to BPs treatment, mainly due to resistance. Use of genetic markers to predict treatment response ...2021-02-03